Immuto Scientific
Pre-clinicalTraditional target discovery methods often overlook pathologic differences in protein structure, leaving critical therapeutic opportunities untapped. At Immuto Scientific, we are pioneering a revolutionary approach by focusing on Surface Protein Conformations (SPCs)—unique, disease-specific protein structures that are invisible to conventional target discovery approaches.
About
Traditional target discovery methods often overlook pathologic differences in protein structure, leaving critical therapeutic opportunities untapped. At Immuto Scientific, we are pioneering a revolutionary approach by focusing on Surface Protein Conformations (SPCs)—unique, disease-specific protein structures that are invisible to conventional target discovery approaches.
Funding History
1Total raised: $3.2M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile